Inspire Medical Systems, based in Minneapolis, Minnesota, is the leading developer of innovative, implantable neurostimulation systems to treat Obstructive Sleep Apnea (OSA). Utilizing well-established technologies from the fields of cardiac pacing and neurostimulation, Inspire has developed a proprietary Upper Airway Stimulation (UAS) therapy which is designed to improve sleep and enrich the lives of people suffering from this challenging condition.
Inspire is funded by prominent medical technology investment firms; GDN Holdings, Kleiner, Perkins, Caufield and Byers, Synergy Life Sciences Partners, US Venture Partners, and Medtronic.
